The phenotypes of bipolar disorder: Relevance for genetic indvestigations

Molecular Psychiatry

Volumn 10, Issue 9, 2005, Pages 811-826

  MacQueen, G M ^a   Hajek, T ^b,c   Alda, M ^b,d  

^a MCMASTER UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c CHARLES UNIVERSITY   (Czech Republic)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Bipolar disorder; Brain imaging; Endophenotype; Genetics; Neurocognitive function

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; OLANZAPINE; VALPROIC ACID;

ANXIETY DISORDER; BASAL GANGLION; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BRAIN DYSFUNCTION; BRAIN SIZE; CHROMOSOME 13Q; CHROMOSOME 18; CHROMOSOME 22Q; CHROMOSOME ANALYSIS; CINGULATE GYRUS; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; COMORBIDITY; DISEASE COURSE; FAMILY; GENE LOCUS; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; LONG TERM CARE; MENTAL DISEASE; MOOD DISORDER; NEUROIMAGING; PANIC; PHENOTYPE; PRIORITY JOURNAL; PROPHYLAXIS; PSYCHOSIS; REVIEW; SUICIDE; SYMPTOM; TREATMENT RESPONSE; VERBAL MEMORY; WHITE MATTER; CHROMOSOME 17; CHROMOSOME MAP; GENETICS; PREVALENCE;

BIPOLAR DISORDER; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 17; COGNITION; COMORBIDITY; HUMANS; PHENOTYPE; PREVALENCE; PSYCHOTIC DISORDERS;

EID: 27744580730     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/sj.mp.4001701     Document Type: Review

References (262)

1. Cardno AG, Marshall EJ, Coid B, Macdonald AM, Ribchester TR, Davies NJ et al. Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch Gen Psychiatry 1999; 56: 162-168.
2. Blackwood DHR, He L, Morris SW, McLean A, Whitton C, Thomson M et al. A locus for bipolar affective disorder on chromosome 4p. Nat Genet 1996; 12: 427-430.
3. Ewald H, Degn B, Mors O, Kruse TA. Support for the possible locus on chromosome 4p16 for bipolar affective disorder. Mol Psychiatry 1998; 3: 442-448.
4. Adams LJ, Mitchell PB, Fielder SL, Rosso A, Donald JA, Schofield PR. A susceptibility locus for bipolar affective disorder on chromosome 4q35. Am J Hum Genet 1998; 62: 1084-1091.
5. Ekholm JM, Kieseppa T, Hiekkalinna T, Partonen T, Paunio T, Perola M et al. Evidence of susceptibility loci on 4q32 and 16p12 for bipolar disorder. Hum Mol Genet 2003; 12: 1907-1915.
6. Cichon S, Schumacher J, Muller DJ, Hurter M, Windemuth C, Strauch K et al. A genome screen for genes predisposing to bipolar affective disorder detects a new susceptibility locus on 8q. Hum Mol Genet 2001; 10: 2933-2944.
7. Dick DM, Foroud T, Flury L, Bowman ES, Miller MJ, Rau NL et al. Genomewide linkage analyses of bipolar disorder: a new sample of 250 pedigrees from the National Institute of Mental Health Genetics Initiative. Am J Hum Genet 2003; 73: 107-114.
8. Detera-Wadleigh SD, Hsieh W, Berrettini WH, Goldin LR, Rollins DY, Muniec D et al. Genetic linkage mapping for a susceptibility locus to bipolar illness: chromosomes 2, 3, 4, 7, 9, 10p, 11p, 22, and Xpter. Am J Med Genet (Neuropsychiat Genet) 1994; 54: 206-218.
9. Foroud T, Castelluccio PF, Koller DL, Edenberg HJ, Miller M, Bowman E et al. Suggestive evidence of a locus on chromosome 10p using the NIMH genetics initiative bipolar affective disorder pedigrees. Am J Med Genet (Neuropsychiat Genet) 2000; 96: 18-23.
10. Morissette J, Villeneuve A, Bordeleau L, Rochette D, Laberge C, Gagne B et al. Genome-wide search for linkage of bipolar affective disorders in a very large pedigree derived from a homogeneous population in Quebec points to a locus of major effect on chromosome 12q23-q24. Am J Med Genet (Neuropsychiat Genet) 1999; 88: 567-587.
11. Degn B, Lundorf MD, Wang A, Vang M, Mors O, Kruse TA et al. Further evidence for a bipolar risk gene on chromosome 12q24 suggested by investigation of haplotype sharing and allelic association in patients from the Faroe Islands. Mol Psychiatry 2001; 6: 450-455.
12. Detera-Wadleigh SD, Badner JA, Berrettini WH, Yoshikawa T, Goldin LR, Turner G et al. A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2. Proc Natl Acad Sci USA 1999; 96: 5604-5609.
13. Badenhop RF, Moses MJ, Scimone A, Mitchell PB, Ewen KR, Rosso A et al. A genome screen of a large bipolar affective disorder pedigree supports evidence for a susceptibility locus on chromosome 13q. Mol Psychiatry 2001; 6: 396-403.
14. Berrettini WH, Ferraro TN, Goldin LR, Weeks DE, Detera-Wadleigh S, Nurnberger JIJ et al. Chromosome 18 DNA markers and manic-depressive illness: evidence for a susceptibility gene. Proc Natl Acad Sci USA 1994; 91: 5918-5921.
15. Stine OC, Xu J, Koskela R, McMahon FJ, Gschwend M, Friddle C et al. Evidence for linkage of bipolar disorder to chromosome 18 with a parent-of-origin effect. Am J Hum Genet 1995; 57: 1384-1394.
16. Freimer NB, Reus VI, Escamilla MA, McInnes LA, Spesny M, Leon P et al. Genetic mapping using haplotype, association and linkage methods suggests a locus for severe bipolar disorder (BPI) at 18q22-q23. Nat Genet 1996; 12: 436-441.
17. Straub RE, Lehner T, Luo Y, Loth JE, Wei S, Sharpe L et al. A possible vulnerability locus for bipolar affective disorder on chromosome 21q22.3. Nat Genet 1994; 8: 291-296.
18. Aita VM, Liu JJ, Knowles JA, Terwilliger JD, Baltazar R, Grunn A et al. A comprehensive linkage analysis of chromosome 21q22 supports prior evidence for a putative bipolar affective disorder locus. Am J Hum Genet 1999; 64: 210-217.
19. Kelsoe JR, Spence MA, Loetscher E, Foguet M, Sadovnick AD, Remick RA et al. A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22. Proc Natl Acad Sci USA 2001; 98: 585-590.
20. Segurado R, Detera-Wadleigh SD, Levinson DF, Lewis CM, Gill M, Nurnberger JI et al. Genome scan metaanalysis of schizophrenia and bipolar disorder. Part III: bipolar disorder. Am J Hum Genet 2003; 73: 49-62.
21. Weaver IC, Cervoni N, Champagne FA, D'Alessio AC, Sharma S, Seckl JR et al. Epigenetic programming by maternal behavior. Nat Neurosci 2004; 7: 847-854.
22. Carroll BJ. Neurobiologic dimensions of depression and mania. In: Angst J (ed). The Origins of Depression: Current Concepts and Approaches. Springer-Verlag: Berlin, 1983, pp 163-186.
23. van Praag HM. Diagnosis, the rate-limiting factor of biological depression research. Neuropsychobiology 1993; 28: 197-206.
24. Cassano GB, Rucci P, Frank E, Fagiolini A, Dell'Osso L, Shear MK et al. The mood spectrum in unipolar and bipolar disorder: arguments for a unitary approach. Am J Psychiatry 2004; 161: 1264-1269.
25. Angst J, Gamma A, Benazzi F, Ajdacic V, Eich D, Rossler W. Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. J Affect Disord 2003; 73: 133-146.
26. Baldessarini RJ. A plea for integrity of the bipolar disorder concept. Bipolar Disord 2000; 2: 3-7.
27. Angst J. The course of affective disorders. Psychopathology 1986; 19(Suppl 2): 47-52.
28. Coryell W, Keller M, Endicott J, Andreasen N, Clayton P, Hirschfeld R. Bipolar II illness: course and outcome over a five-year period. Psychol Med 1989; 19: 129-141.
29. Koukopoulos A, Reginaldi D, Laddomada P, Floris G, Serra G, Tondo L. Course of the manic-depressive cycle and changes caused by treatment. Pharmakopsychiatr Neuropsychopharmakol 1980; 13: 156-167.
30. Cassano GB, Akiskal HS, Savino M, Musetti L, Perugi G. Proposed subtypes of bipolar II and related disorders: with hypomanic episodes (or cyclothymia) and with hyperthymic temperament. J Affect Disord 1992; 26: 127-140.
31. Benazzi F. A comparison of the age of onset of bipolar I and bipolar II outpatients. J Affect Disord 1999; 54: 249-253.
32. MacQueen GM, Young LT. Bipolar II disorder: symptoms, course, and response to treatment. Psychiatr Serv 2001; 52: 358-361.
33. Coryell W, Endicott J, Reich T, Andreasen NC, Keller M. A family study of bipolar II disorder. Br J Psychiatry 1984; 145: 49-54.
34. Endicott J, Nee J, Andreasen N, Clayton P, Keller M, Coryell W. Bipolar II. Combine or keep separate? J Affect Disord 1985; 8: 17-28.
35. Simpson SG, Folstein SE, Meyers DA, McMahon FJ, Brusco DM, DePaulo JRJ. Bipolar II: the most common bipolar phenotype? Am J Psychiatry 1993; 150: 901-903.
36. McMahon FJ, Simpson SG, McInnis MG, Badner JA, MacKinnon DF, DePaulo JR. Linkage of bipolar disorder to chromosome 18q and the validity of bipolar II disorder. Arch Gen Psychiatry 2001; 58: 1025-1031.
37. Reich W. The spectrum concept of schizophrenia. Problems for diagnostic practice. Arch Gen Psychiatry 1975; 32: 489-498.
38. Rosenthal D. The spectrum concept in schizophrenic and manic-depressive disorders. Res Publ Assoc Res Nerv Ment Dis 1975; 54: 19-25.
39. Akiskal HS, Djenderedjian AM, Rosenthal RH, Khani MK. Cyclothymic disorder: validating criteria for inclusion in the bipolar affective group. Am J Psychiatry 1977; 134: 1227-1233.
40. Blacker D, Lavori PW, Faraone SV, Tsuang MT. Unipolar relatives in bipolar pedigrees: a search for indicators of underlying bipolarity. Am J Med Genet (Neuropsychiat Genet) 1993; 48: 192-199.
41. Blacker D, Tsuang MT. Unipolar relatives in bipolar pedigrees: are they bipolar? Psychiat Genet 1993; 3: 5-16.
42. Gershon ES, Hamovit J, Guroff JJ, Dibble E, Leckman JF, Sceery W et al. A family study of schizoaffective, bipolar I, bipolar II, unipolar and normal control probands. Arch Gen Psychiatry 1982; 39: 1157-1167.
43. McCarthy MI, Froguel P. Genetic approaches to the molecular understanding of type 2 diabetes. Am J Physiol Endocrinol Metab 2002; 283: E217-E225.
44. Field LL. Genetic linkage and association studies of Type I diabetes: challenges and rewards. Diabetologia 2002; 45: 21-35.
45. Bowcock AM. Molecular cloning of BRCA1: a gene for early onset familial breast and ovarian cancer. Breast Cancer Res Treat 1993; 28: 121-135.
46. Shifman S, Darvasi A. The value of isolated populations. Nat Genet 2001; 28: 309-310.
47. Tanzi RE, Bertram L. New frontiers in Alzheimer's disease genetics. Neuron 2001; 32: 181-184.
48. Gibbs M, Stanford JL, Jarvik GP, Janer M, Badzioch M, Peters MA et al. A genomic scan of families with prostate cancer identifies multiple regions of interest. Am J Hum Genet 2000; 67: 100-109.
49. Kaneko S, Okada M, Iwasa H, Yamakawa K, Hirose S. Genetics of epilepsy: current status and perspectives. Neurosci Res 2002; 44: 11-30.
50. Robbins DH, Itzkowitz SH. The molecular and genetic basis of colon cancer. Med Clin N Am 2002; 86: 1467-1495.
51. Nurnberger JIJ. Implications of multifactorial inheritance for identification of genetic mechanisms in major psychiatric disorders. Psychiat Genet 2002; 12: 121-126.
52. Berrettini WH. Are schizophrenic and bipolar disorders related? A review of family and molecular studies. Biol Psychiatry 2000; 48: 531-538.
53. Gershon ES. Bipolar illness and schizophrenia as oligogenic diseases: implications for the future. Biol Psychiatry 2000; 47: 240-244.
54. Ketter TA, Wang PW, Becker OV, Nowakowska C, Yang Y. Psychotic bipolar disorders: dimensionally similar to or categorically different from schizophrenia? J Psychiat Res 2004; 38: 47-61.
55. Potash JB, Willour VL, Chiu YF, Simpson SG, MacKinnon DF, Pearlson GD et al. The familial aggregation of psychotic symptoms in bipolar disorder pedigrees. Am J Psychiatry 2001; 158: 1258-1264.
56. Potash JB, Chiu YF, MacKinnon DF, Miller EB, Simpson SG, McMahon FJ et al. Familial aggregation of psychotic symptoms in a replication set of 69 bipolar disorder pedigrees. Am J Med Genet (Neuropsychiat Genet) 2003; 116B: 90-97.
57. Schurhoff F, Szoke A, Meary A, Bellivier F, Rouillon F, Pauls D et al. Familial aggregation of delusional proneness in schizophrenia and bipolar pedigrees. Am J Psychiatry 2003; 160: 1313-1319.
58. O'Mahony E, Corvin A, O'Connell R, Comerford C, Larsen B, Jones R et al. Sibling pairs with affective disorders: resemblance of demographic and clinical features. Psychol Med 2002; 32: 55-61.
59. Potash JB, Zandi PP, Willour VL, Lan TH, Huo Y, Avramopoulos D et al. Suggestive linkage to chromosomal regions 13q31 and 22q12 in families with psychotic bipolar disorder. Am J Psychiatry 2003; 160: 680-686.
60. Liu C, Badner JA, Christian SL, Guroff JJ, Detera-Wadleigh SD, Gershon ES. Fine mapping supports previous linkage evidence for a bipolar disorder susceptibility locus on 13q32. Am J Med Genet (Neuropsychiat Genet) 2001; 105: 375-380.
61. Chen YS, Akula N, Detera-Wadleigh SD, Schulze TG, Thomas J, Potash JB et al. Findings in an independent sample support an association between bipolar affective disorder and the G72/G30 locus on chromosome 13q33. Mol Psychiatry 2004; 9: 87-92.
62. Jorgensen TH, Borglum AD, Mors O, Wang AG, Pinaud M, Flint TJ et al. Search for common haplotypes on chromosome 22q in patients with schizophrenia or bipolar disorder from the Faroe Islands. Am J Med Genet (Neuropsychiat Genet) 2002; 114: 245-252.
63. Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, Palicio M, Abderrahim H et al. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci USA 2002; 99: 13675-13680.
64. Addington AM, Gornick M, Sporn AL, Gogtay N, Greenstein D, Lenane M et al. Polymorphisms in the 13q33.2 gene G72/G30 are associated with childhood-onset schizophrenia and psychosis not otherwise specified. Biol Psychiatry 2004; 55: 976-980.
65. Pulver AE, Karayiorgou M, Wolyniec PS, Lasseter VK, Kasch L, Nestadt G et al. Sequential strategy to identify a susceptibility gene for schizophrenia: report of potential linkage on chromosome 22q12-q13.1: part 1. Am J Med Genet (Neuropsychiat Genet) 1994; 54: 36-43.
66. Bassett AS, Chow EW. 22q11 deletion syndrome: a genetic subtype of schizophrenia. Biol Psychiatry 1999; 46: 882-891.
67. Gill M, Vallada H, Collier D, Sham P, Holmans P, Murray R et al. A combined analysis of D22S278 marker alleles in affected sibpairs: support for a susceptibility locus for schizophrenia at chromosome 22q12. Schizophrenia Collaborative Linkage Group (Chromosome 22). Am J Med Genet (Neuropsychiat Genet) 1996; 67: 40-45.
68. Schwab SG, Lerer B, Albus M, Maier W, Hallmayer J, Fimmers R et al. Potential linkage for schizophrenia on chromosome 22q12-q13: a replication study. Am J Med Genet (Neuropsychiat Genet) 1995; 60: 436-443.
69. Kalsi G, Brynjolfsson J, Butler R, Sherrington R, Curtis D, Sigmundsson T et al. Linkage analysis of chromosome 22q12-13 in a United Kingdom/Icelandic sample of 23 multiplex schizophrenia families. Am J Med Genet (Neuropsychiat Genet) 1995; 60: 298-301.
70. Liu H, Abecasis GR, Heath SC, Knowles A, Demars S, Chen YJ et al. Genetic variation in the 22q11 locus and susceptibility to schizophrenia. Proc Natl Acad Sci USA 2002; 99: 16859-16864.
71. Park N, Juo SH, Cheng R, Liu J, Loth JE, Lilliston B et al. Linkage analysis of psychosis in bipolar pedigrees suggests novel putative loci for bipolar disorder and shared susceptibility with schizophrenia. Mol Psychiatry 2004; 9: 1091-1099.
72. Cassano GB, Pini S, Saettoni M, Dell'Osso L. Multiple anxiety disorder comorbidity in patients with mood spectrum disorders with psychotic features. Am J Psychiatry 1999; 156: 474-476.
73. Pini S, Cassano GB, Simonini E, Savino M, Russo A, Montgomery SA. Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia. J Affect Disord 1997; 42: 145-153.
74. McElroy SL, Altshuler LL, Suppes T, Keck PEJ, Frye MA, Denicoff KD et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry 2001; 158: 420-426.
75. Chen YW, Dilsaver SC. Comorbidity of panic disorder in bipolar illness: evidence from the Epidemiologic Catchment Area Survey. Am J Psychiatry 1995; 152: 280-282.
76. Perugi G, Akiskal HS, Toni C, Simonini E, Gemignani A. The temporal relationship between anxiety disorders and (hypo)mania: a retrospective examination of 63 panic, social phobic and obsessive-compulsive patients with comorbid bipolar disorder. J Affect Disord 2001; 67: 199-206.
77. Feske U, Frank E, Mallinger AG, Houck PR, Fagiolini A, Shear MK et al. Anxiety as a correlate of response to the acute treatment of bipolar I disorder. Am J Psychiatry 2000; 157: 956-962.
78. Joffe RT, Bagby RM, Levitt A. Anxious and nonanxious depression. Am J Psychiatry 1993; 150: 1257-1258.
79. Keck Jr PE, McElroy SL, Strakowski SM, West SA, Sax KW, Hawkins JM et al. 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Am J Psychiatry 1998; 155: 646-652.
80. Himmelhoch JM, Garfinkel ME. Sources of lithium resistance in mixed mania. Psychopharmacol Bull 1986; 22: 613-620.
81. McElroy SL, Strakowski SM, Keck Jr PE, Tugrul KL, West SA, Lonczak HS. Differences and similarities in mixed and pure mania. Compr Psychiatry 1995; 36: 187-194.
82. Young LT, Cooke RG, Robb JC, Levitt AJ, Joffe RT. Anxious and non-anxious bipolar disorder. J Affect Disord 1993; 29: 49-52.
83. Sonne SC, Brady KT, Morton WA. Substance abuse and bipolar affective disorder. J Nerv Ment Dis 1994; 182: 349-352.
84. Savino M, Perugi G, Simonini E, Soriani A, Cassano GB, Akiskal HS. Affective comorbidity in panic disorder: is there a bipolar connection? J Affect Disord 1993; 28: 155-163.
85. Endicott NA. Psychophysiological correlates of 'bipolarity'. J Affect Disord 1989; 17: 47-56.
86. DePaulo JRJ, Simpson SG. Therapeutic and genetic prospects of an atypical affective disorder. J Clin Psychopharmacol 1987; 7: 50S-54S.
87. Kovacs M, Pollock M. Bipolar disorder and comorbid conduct disorder in childhood and adolescence. J Am Acad Child Adolescent Psychiatry 1995; 34: 715-723.
88. Weller EB, Weller RA, Fristad MA. Bipolar disorder in children: misdiagnosis, underdiagnosis, and future directions. J Am Acad Child Adolescent Psychiatry 1995; 34: 709-714.
89. Angst J, Angst F, Stassen HH. Suicide risk in patients with major depressive disorder. J Clin Psychiatry 1999; 60(Suppl 2): 57-62.
90. Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, Keller M et al. Switching from 'unipolar' to bipolar II. An 11-year prospective study of clinical and temperamental predictors in 559 patients. Arch Gen Psychiatry 1995; 52: 114-123.
91. Perugi G, Toni C, Akiskal HS. Anxious-bipolar comorbidity. Diagnostic and treatment challenges. Psychiat Clin N Am 1999; 22: 565-583, viii.
92. Himmelhoch JM. Social anxiety, hypomania and the bipolar spectrum: data, theory and clinical issues. J Affect Disord 1998; 50: 203-213.
93. Kupfer DJ, Carpenter LL, Frank E. Is bipolar II a unique disorder? Compr Psychiatry 1988; 29: 228-236.
94. Cooke RG, Young LT, Levitt AJ, Pearce MM, Joffe RT. Bipolar II: not so different when co-morbidity is excluded. Depression 1995; 3: 154-156.
95. MacKinnon DF, McMahon FJ, Simpson SJ, McInnis MG, DePaulo JR. Panic disorder with familial bipolar disorder. Biol Psychiatry 1997; 42: 90-95.
96. MacKinnon DF, Zandi P, Cooper J, Potash JB, Simpson SG, Gershon E et al. Comorbid bipolar disorder and panic disorder in families with a high prevalence of bipolar disorder. Am J Psychiatry 2002; 159: 30-35.
97. MacKinnon DF, Zandi PP, Gershon E, Nurnberger JIJ, Reich T, DePaulo JR. Rapid switching of mood in families with multiple cases of bipolar disorder. Arch Gen Psychiatry 2003; 60: 921-928.
98. MacKinnon DF, Zandi PP, Gershon ES, Nurnberger JIJ, DePaulo JRJ. Association of rapid mood switching with panic disorder and familial panic risk in familial bipolar disorder. Am J Psychiatry 2003; 160: 1696-1698.
99. MacKinnon DF, Xu J, McMahon FJ, Simpson SG, Stine OC, McInnis MG et al. Bipolar disorder and panic disorder in families: an analysis of chromosome 18 data. Am J Psychiatry 1998; 155: 829-831.
100. Turecki G, Grof P, Cavazzoni P, Duffy A, Grof E, Martin R et al. Lithium responsive bipolar disorder, unilineality, and chromosome 18: a linkage study. Am J Med Genet (Neuropsychiat Genet) 1999; 88: 411-415.
101. Turecki G, Grof P, Grof E, D'Souza V, Lebuis L, Marineau C et al. Mapping susceptibility genes for bipolar disorder: a pharmacogenetic approach based on excellent response to lithium. Mol Psychiatry 2001; 6: 570-578.
102. Grof P, Alda M, Grof E, Zvolsky P, Walsh M. Lithium response and genetics of affective disorders. J Affect Disord 1994; 32: 85-95.
103. Passmore M, Garnham J, Duffy A, MacDougall M, Munro A, Slaney C et al. Phenotypic spectra of bipolar disorder in responders to lithium vs lamotrigine. Bipolar Disord 2003; 5: 110-114.
104. Preisig M, Fenton BT, Stevens DE, Merikangas KR. Familial relationship between mood disorders and alcoholism. Compr Psychiatry 2001; 42: 87-95.
105. Levin FR, Hennessy G. Bipolar disorder and substance abuse. Biol Psychiatry 2004; 56: 738-748.
106. Bellivier F, Golmard JL, Rietschel M, Schulze TG, Malafosse A, Preisig M et al. Age at onset in bipolar 1 affective disorder: further evidence for three subgroups. Am J Psychiatry 2003; 160: 999-1001.
107. Faraone SV, Glatt SJ, Su J, Tsuang MT. Three potential susceptibility loci shown by a genome-wide scan for regions influencing the age at onset of mania. Am J Psychiatry 2004; 161: 625-630.
108. Dion GL, Tohen M, Anthony WA, Waternaux CS. Symptoms and functioning of patients with bipolar disorder six months after hospitalization. Hosp Commun Psychiatry 1988; 39: 652-657.
109. O'Connell RA, Mayo JA, Flatow L, Cuthbertson B, O'Brien BE. Outcome of bipolar disorder on long-term treatment with lithium. Br J Psychiatry 1991; 159: 123-129.
110. Tohen M, Waternaux CM, Tsuang MT. Outcome in mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis. Arch Gen Psychiatry 1990; 47: 1106-1111.
111. Goldberg JF, Harrow M, Grossman LS. Recurrent affective syndromes in bipolar and unipolar mood disorders at follow-up. Br J Psychiatry 1995; 166: 382-385.
112. Goldberg JF, Harrow M, Grossman LS. Course and outcome in bipolar affective disorder: a longitudinal follow-up study. Am J Psychiatry 1995; 152: 379-384.
113. Staner L, Tracy A, Dramaix M, Genevrois C, Vanderelst M, Vilane A et al. Clinical and psychosocial predictors of recurrence in recovered bipolar and unipolar depressives: a one-year controlled prospective study. Psychiatry Res 1997; 69: 39-51.
114. MacQueen GM, Young LT, Robb JC, Marriott M, Cooke RG, Joffe RT. Effect of number of episodes on wellbeing and functioning of patients with bipolar disorder. Acta Psychiat Scand 2000; 101: 374-381.
115. MacQueen GM, Young LT, Robb JC, Cooke RG, Joffe RT. Levels of functioning and well-being in recovered psychotic vs nonpsychotic mania. J Affect Disord 1997; 46: 69-72.
116. Duffy A, Alda M, Kutcher S, Cavazzoni P, Robertson C, Grof E et al. A prospective study of the offspring of bipolar parents responsive and nonresponsive to lithium treatment. J Clin Psychiatry 2002; 63: 1171-1178.
117. Rihmer Z, Pestality P. Bipolar II disorder and suicidal behavior. Psychiat Clin N Am 1999; 22: 667-673.
118. Fu Q, Heath AC, Bucholz KK, Nelson EC, Glowinski AL, Goldberg J et al. A twin study of genetic and environmental influences on suicidality in men. Psychol Med 2002; 32: 11-24.
119. Cavazzoni P, Grof P, Duffy A, Grof E, Zvolsky P, Alda M. A family study of suicidal behaviour in bipolar-spectrum disorders. Bipolar Disord 1999; 1(Suppl 1): 27.
120. Slama F, Bellivier F, Henry C, Rousseva A, Etain B, Rouillon F et al. Bipolar patients with suicidal behavior: toward the identification of a clinical subgroup. J Clin Psychiatry 2004; 65: 1035-1039.
121. Joyce PR, Doughty CJ, Wells JE, Walsh AE, Admiraal A, Lill M et al. Affective disorders in the first-degree relatives of bipolar probands: results from the South Island Bipolar Study. Compr Psychiatry 2004; 45: 168-174.
122. Soares JC, Gershon S. The diagnostic boundaries of bipolar disorder. Bipolar Disord 2000; 2: 1-2.
123. Grof P, Alda M, Grof E, Fox D, Cameron P. The challenge of predicting response to stabilising lithium treatment. The importance of patient selection. Br J Psychiatry 1993; 163(Suppl 21): 16-19.
124. Calabrese JR, Fatemi SH, Kujawa M, Woyshville MJ. Predictors of response to mood stabilizers. J Clin Psychopharmacol 1996; 16: 24S-31S.
125. Bowden CL. Clinical correlates of therapeutic response in bipolar disorder. J Affect Disord 2001; 67: 257-265.
126. Mendlewicz J, Fieve RR, Stallone F. Relationship between the effectiveness of lithium therapy and family history. Am J Psychiatry 1973; 130: 1011-1013.
127. Zvolsky P, Vinarova E, Dostal T, Soucek K. Family history of manic-depressive and endogenous depresive patients and clinical effect of treatment with lithium. Activ Nerv Super 1974; 16: 194-195.
128. Prien RF, Caffey EM, Klett CJ. Factors associated with treatment success in lithium carbonate prophylaxis: report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Arch Gen Psychiatry 1974; 31: 189-192.
129. Svestka J. Therapy and prophylaxis of manic-depressive psychosis with lithium carbonate, with respect to possibility of prediction of the therapeutic result. Acta Fac Med Univ Brunensis 1979; 65: 25-102.
130. Maj M, Del Vecchio M, Starace F, Pirozzi R, Kemali D. Prediction of affective psychoses response to lithium prophylaxis: the role of socio-demographic, clinical, psychological and biological variables. Acta Psychiat Scand 1984; 69: 37-44.
131. Smeraldi E, Petroccione A, Gasperini M, Macciardi F, Orsini A, Kidd KK. Outcomes on lithium treatment as a tool for genetic studies in affective disorders. J Affect Disord 1984; 6: 139-151.
132. Grof P, Duffy A, Cavazzoni P, Grof E, Garnham J, MacDougall M et al. Is response to prophylactic lithium a familial trait? J Clin Psychiatry 2002; 63: 942-947.
133. Alda M, Grof P, Grof E, Zvolsky P, Walsh M. Mode of inheritance in families of patients with lithium-responsive affective disorders. Acta Psychiat Scand 1994; 90: 304-310.
134. Alda M, Grof E, Cavazzoni P, Duffy A, Martin R, Ravindran L et al. Autosomal recessive inheritance of affective disorders in families of responders to lithium prophylaxis? J Affect Disord 1997; 44: 153-157.
135. Gershon ES, Baron M, Leckman JF. Genetic models of the transmission of affective disorders. J Psychiat Res 1975; 12: 301-317.
136. Post RM, Uhde TW, Roy-Byrne PP, Joffe RT. Correlates of antimanic response to carbamazepine. Psychiatry Res 1987; 21: 71-83.
137. Swann AC, Bowden CL, Morris D, Calabrese JR, Petty F, Small J et al. Depression during mania. Treatment response to lithium or divalproex. Arch Gen Psychiatry 1997; 54: 37-42.
138. Greil W, Ludwig-Mayerhofer W, Erazo N, Schochlin C, Schmidt S, Engel RR et al. Lithium vs carbamazepine in the maintenance treatment of bipolar disorders - a randomised study. J Affect Disord 1997; 43: 151-161.
139. Soares JC, Gershon S. The lithium ion: a foundation for psychopharmacological specificity. Neuropsychopharmacology 1998; 19: 167-182.
140. Tohen M, Chengappa KN, Suppes T, Zarate CAJ, Calabrese JR, Bowden CL et al. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry 2002; 59: 62-69.
141. Baker RW, Goldberg JF, Tohen M, Milton DR, Stauffer VL, Schuh LM. The impact of response to previous mood stabilizer therapy on response to olanzapine vs placebo for acute mania. Bipolar Disord 2002; 4: 43-49.
142. Detera-Wadleigh SD. Lithium-related genetics of bipolar disorder. Ann Med 2001; 33: 272-285.
143. Lenox RH, Gould TD, Manji HK. Endophenotypes in bipolar disorder. Am J Med Genet (Neuropsychiat Genet) 2002; 114: 391-406.
144. Simpson SG, Folstein SE, Meyers DA, DePaulo JR. Assessment of lineality in bipolar I linkage studies. Am J Psychiatry 1992; 149: 1660-1665.
145. McMahon FJ, Stine OC, Meyers DA, Simpson SG, DePaulo JR. Patterns of maternal transmission in bipolar affective disorder. Am J Hum Genet 1995; 56: 1277-1286.
146. Washizuka S, Kakiuchi C, Mori K, Kunugi H, Tajima O, Akiyama T et al. Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with bipolar disorder. Am J Med Genet (Neuropsychiat Genet) 2003; 120B: 72-78.
147. Washizuka S, Iwamoto K, Kazuno AA, Kakiuchi C, Mori K, Kametani M et al. Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with bipolar disorder in Japanese and the National Institute of Mental Health pedigrees. Biol Psychiatry 2004; 56: 483-489.
148. O'Donovan M, Jones I, Craddock N. Anticipation and repeat expansion in bipolar disorder. Am J Med Genet (Neuropsychiat Genet) 2003; 123C: 10-17.
149. Heinzmann A, Deichmann KA. Genes for atopy and asthma. Curr Opin Allergy Clin Immunol 2001; 1: 387-392.
150. Luft FC. Hypertension as a complex genetic trait. Semin Nephrol 2002; 22: 115-126.
151. Timberlake DS, O'Connor DT, Parmer RJ. Molecular genetics of essential hypertension: recent results and emerging strategies. Curr Opin Nephrol Hypertens 2001; 10: 71-79.
152. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003; 160: 636-645.
153. Glahn DC, Bearden CE, Niendam TA, Escamilla MA. The feasibility of neuropsychological endophenotypes in the search for genes associated with bipolar affective disorder. Bipolar Disord 2004; 6: 171-182.
154. Kessing LV. Cognitive impairment in the euthymic phase of affective disorder. Psychol Med 1998; 28: 1027-1038.
155. Ferrier IN, Stanton BR, Kelly TP, Scott J. Neuropsychological function in euthymic patients with bipolar disorder. Br J Psychiatry 1999; 175: 246-251.
156. Scott J, Stanton B, Garland A, Ferrier IN. Cognitive vulnerability in patients with bipolar disorder. Psychol Med 2000; 30: 467-472.
157. Thompson JM, Gray JM, Ferrier IN, Hughes JH, Watson S, Young AH. A component process analysis of working memory dysfunction in prospectively verified euthymic bipolar patients. Bipolar Disord 2001; 3(Suppl 1): 60.
158. Cavanagh JT, Van Beck M, Muir W, Blackwood DH. Case-control study of neurocognitive function in euthymic patients with bipolar disorder: an association with mania. Br J Psychiatry 2002; 180: 320-326.
159. Harmer CJ, Clark L, Grayson L, Goodwin GM. Sustained attention deficit in bipolar disorder is not a working memory impairment in disguise. Neuropsychologia 2002; 40: 1586-1590.
160. Clark L, Iversen SD, Goodwin GM. Sustained attention deficit in bipolar disorder. Br J Psychiatry 2002; 180: 313-319.
161. Rubinsztein JS, Michael A, Paykel ES, Sahakian BJ. Cognitive impairment in remission in bipolar affective disorder. Psychol Med 2000; 30: 1025-1036.
162. Tham A, Engelbrektson K, Mathe AA, Johnson L, Olsson E, Aberg-Wistedt A. Impaired neuropsychological performance in euthymic patients with recurring mood disorders. J Clin Psychiatry 1997; 58: 26-29.
163. MacQueen GM, Young LT, Galway TM, Joffe RT. Backward masking task performance in stable euthymic out-patients with bipolar disorder. Psychol Med 2001; 31: 1269-1277.
164. van Gorp WG, Altshuler LL, Theberge DC, Wilkins J, Dixon W. Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. A preliminary study. Arch Gen Psychiatry 1998; 55: 41-46.
165. Macqueen G, Young T. Cognitive effects of atypical antipsychotics: focus on bipolar spectrum disorders. Bipolar Disord 2003; 5(Suppl 2): 53-61.
166. Deshauer D, Grof E, Alda M, Grof P. Patterns of DST positivity in remitted affective disorders. Biol Psychiatry 1999; 45: 1023-1029.
167. Watson S, Gallagher P, Ritchie JC, Ferrier IN, Young AH. Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder. Br J Psychiatry 2004; 184: 496-502.
168. Gourovitch ML, Torrey EF, Gold JM, Randolph C, Weinberger DR, Goldberg TE. Neuropsychological performance of monozygotic twins discordant for bipolar disorder. Biol Psychiatry 1999; 45: 639-646.
169. Keri S, Kelemen O, Benedek G, Janka Z. Different trait markers for schizophrenia and bipolar disorder: a neurocognitive approach. Psychol Med 2001; 31: 915-922.
170. Sobczak S, Riedel WJ, Booij I, Aan HR, Deutz NE, Honig A. Cognition following acute tryptophan depletion: difference between first-degree relatives of bipolar disorder patients and matched healthy control volunteers. Psychol Med 2002; 32: 503-515.
171. Sobczak S, Honig A, Schmitt JA, Riedel WJ. Pronounced cognitive deficits following an intravenous L-tryptophan challenge in first-degree relatives of bipolar patients compared to healthy controls. Neuropsychopharmacology 2003; 28: 711-719.
172. Ferrier IN, Chowdhury R, Thompson JM, Watson S, Young AH. Neurocognitive function in unaffected first-degree relatives of patients with bipolar disorder: a preliminary report. Bipolar Disord 2004; 6: 319-322.
173. Zalla T, Joyce C, Szoke A, Schurhoff F, Pillon B, Komano O et al. Executive dysfunctions as potential markers of familial vulnerability to bipolar disorder and schizophrenia. Psychiatry Res 2004; 121: 207-217.
174. Altshuler LL, Ventura J, van Gorp WG, Green MF, Theberge DC, Mintz J. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects. Biol Psychiatry 2004; 56: 560-569.
175. McDonough-Ryan P, DelBello M, Shear PK, Ris DM, Soutullo C, Strakowski SM. Academic and cognitive abilities in children of parents with bipolar disorder: a test of the nonverbal learning disability model. J Clin Exp Neuropsychol 2002; 24: 280-285.
176. Kestenbaum CJ. Children at risk for manic-depressive illness: possible predictors. Am J Psychiatry 1979; 136: 1206-1208.
177. Decina P, Kestenbaum CJ, Farber S, Kron L, Gargan M, Sackeim HA et al. Clinical and psychological assessment of children of bipolar probands. Am J Psychiatry 1983; 140: 548-553.
178. MacQueen GM, Grof P, Alda M, Marriott M, Young LT, Duffy A. A pilot study of visual backward masking performance among affected vs unaffected offspring of parents with bipolar disorder. Bipolar Disord 2004; 6: 374-378.
179. Rybakowski JK, Borkowska A, Czerski PM, Skibinska M, Hauser J. Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients. Bipolar Disord 2003; 5: 468-472.
180. Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet 2002; 71: 651-655.
181. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996; 6: 243-250.
182. Clark L, Goodwin GM. State- and trait-related deficits in sustained attention in bipolar disorder. Eur Arch Psychiatry Clin Neurosci 2004; 254: 61-68.
183. Yatham LN, Liddle PF, Lam RW, Shiah IS, Lane C, Stoessl AJ et al. PET study of the effects of valproate on dopamine D(2) receptors in neuroleptic- and mood-stabilizer-naive patients with nonpsychotic mania. Am J Psychiatry 2002; 159: 1718-1723.
184. Bartley AJ, Jones DW, Weinberger DR. Genetic variability of human brain size and cortical gyral patterns. Brain 1997; 120(Part 2): 257-269.
185. Thompson P, Cannon TD, Toga AW. Mapping genetic influences on human brain structure. Ann Med 2002; 34: 523-536.
186. Baare WF, Hulshoff PH, Boomsma DI, Posthuma D, de Geus EJ, Schnack HG et al. Quantitative genetic modeling of variation in human brain morphology. Cereb Cortex 2001; 11: 816-824.
187. Wright IC, Sham P, Murray RM, Weinberger DR, Bullmore ET. Genetic contributions to regional variability in human brain structure: methods and preliminary results. Neuroimage 2002; 17: 256-271.
188. Scamvougeras A, Kigar DL, Jones D, Weinberger DR, Witelson SF. Size of the human corpus callosum is genetically determined: an MRI study in mono and dizygotic twins. Neurosci Lett 2003; 338: 91-94.
189. Pfefferbaum A, Sullivan EV, Swan GE, Carmelli D. Brain structure in men remains highly heritable in the seventh and eighth decades of life. Neurobiol Aging 2000; 21: 63-74.
190. Sullivan EV, Pfefferbaum A, Swan GE, Carmelli D. Heritability of hippocampal size in elderly twin men: equivalent influence from genes and environment. Hippocampus 2001; 11: 754-762.
191. Strakowski SM, DelBello MP, Adler CM. The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Mol Psychiatry 2005; 10: 105-116.
192. McDonald C, Zanelli J, Rabe-Hesketh S, Ellison-Wright I, Sham P, Kalidindi S et al. Meta-analysis of magnetic resonance imaging brain morphometry studies in bipolar disorder. Biol Psychiatry 2004; 56: 411-417.
193. Lim KO, Rosenbloom MJ, Faustman WO, Sullivan EV, Pfefferbaum A. Cortical gray matter deficit in patients with bipolar disorder. Schizophr Res 1999; 40: 219-227.
194. Lopez-Larson MP, DelBello MP, Zimmerman ME, Schwiers ML, Strakowski SM. Regional prefrontal gray and white matter abnormalities in bipolar disorder. Biol Psychiatry 2002; 52: 93-100.
195. Sassi RB, Nicoletti M, Brambilla P, Mallinger AG, Frank E, Kupfer DJ et al. Increased gray matter volume in lithium-treated bipolar disorder patients. Neurosci Lett 2002; 329: 243-245.
196. Bearden CE, Hoffman KM, Cannon TD. The neuropsychology and neuroanatomy of bipolar affective disorder: a critical review. Bipolar Disord 2001; 3: 106-150.
197. Ahn KH, Lyoo IK, Lee HK, Song IC, Oh JS, Hwang J et al. White matter hyperintensities in subjects with bipolar disorder. Psychiatry Clin Neurosci 2004; 58: 516-521.
198. Silverstone T, McPherson H, Li Q, Doyle T. Deep white matter hyperintensities in patients with bipolar depression, unipolar depression and age-matched control subjects. Bipolar Disord 2003; 5: 53-57.
199. Sassi RB, Brambilla P, Nicoletti M, Mallinger AG, Frank E, Kupfer DJ et al. White matter hyperintensities in bipolar and unipolar patients with relatively mild-to-moderate illness severity. J Affect Disord 2003; 77: 237-245.
200. Pillai JJ, Friedman L, Stuve TA, Trinidad S, Jesberger JA, Lewin JS et al. Increased presence of white matter hyperintensities in adolescent patients with bipolar disorder. Psychiatry Res 2002; 114: 51-56.
201. Brambilla P, Barale F, Caverzasi E, Soares JC. Anatomical MRI findings in mood and anxiety disorders. Epidemiol Psichiatr Soc 2002; 11: 88-99.
202. Soares JC, Mann JJ. The anatomy of mood disorders - review of structural neuroimaging studies. Biol Psychiatry 1997; 41: 86-106.
203. Drevets WC, Price JL, Simpson Jr JR, Todd RD, Reich T, Vannier M et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997; 386: 824-827.
204. Sharma V, Menon R, Carr TJ, Densmore M, Mazmanian D, Williamson PC. An MRI study of subgenual prefrontal cortex in patients with familial and non-familial bipolar I disorder. J Affect Disord 2003; 77: 167-171.
205. Sheline YI, Sanghavi M, Mintun MA, Gado MH. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 1999; 19: 5034-5043.
206. Noga JT, Vladar K, Torrey EF. A volumetric magnetic resonance imaging study of monozygotic twins discordant for bipolar disorder. Psychiatry Res 2001; 106: 25-34.
207. Aylward EH, Roberts-Twillie JV, Barta PE, Kumar AJ, Harris GJ, Geer M et al. Basal ganglia volumes and white matter hyper-intensities in patients with bipolar disorder. Am J Psychiatry 1994; 151: 687-693.
208. Beyer JL, Kuchibhatla M, Payne M, Moo-Young M, Cassidy F, MacFall J et al. Caudate volume measurement in older adults with bipolar disorder. Int J Geriatr Psychiatry 2004; 19: 109-114.
209. Brambilla P, Harenski K, Nicoletti MA, Mallinger AG, Frank E, Kupfer DJ et al. Anatomical MRI study of basal ganglia in bipolar disorder patients. Psychiatry Res 2001; 106: 65-80.
210. Sax KW, Strakowski SM, Zimmerman ME, DelBello MP, Keck Jr PE, Hawkins JM. Frontosubcortical neuroanatomy and the continuous performance test in mania. Am J Psychiatry 1999; 156: 139-141.
211. Swayze VW, Andreasen NC, Alliger RJ, Yuh WT, Ehrhardt JC. Subcortical and temporal structures in affective disorder and schizophrenia: a magnetic resonance imaging study. Biol Psychiatry 1992; 31: 221-240.
212. Strakowski SM, Wilson DR, Tohen M, Woods BT, Douglass AW, Stoll AL. Structural brain abnormalities in first-episode mania. Biol Psychiatry 1993; 33: 602-609.
213. Eliez S, Blasey CM, Freund LS, Hastie T, Reiss AL. Brain anatomy, gender and IQ in children and adolescents with fragile X syndrome. Brain 2001; 124: 1610-1618.
214. Kates WR, Burnette CP, Bessette BA, Folley BS, Strunge L, Jabs EW et al. Frontal and caudate alterations in velocardiofacial syndrome (deletion at chromosome 22q11.2). J Child Neurol 2004; 19: 337-342.
215. Heitmiller DR, Nopoulos PC, Andreasen NC. Changes in caudate volume after exposure to atypical neuroleptics in patients with schizophrenia may be sex-dependent. Schizophr Res 2004; 66: 137-142.
216. Strakowski SM, DelBello MP, Sax KW, Zimmerman ME, Shear PK, Hawkins JM et al. Brain magnetic resonance imaging of structural abnormalities in bipolar disorder. Arch Gen Psychiatry 1999; 56: 254-260.
217. Ahearn EP, Steffens DC, Cassidy F, Van Meter SA, Provenzale JM, Seldin MF et al. Familial leukoencephalopathy in bipolar disorder. Am J Psychiatry 1998; 155: 1605-1607.
218. Altshuler LL, Curran JG, Hauser P, Mintz J, Denicoff K, Post R. T2 hyperintensities in bipolar disorder: magnetic resonance imaging comparison and literature meta-analysis. Am J Psychiatry 1995; 152: 1139-1144.
219. Videbech P. MRI findings in patients with affective disorder: a meta-analysis. Acta Psychiat Scand 1997; 96: 157-168.
220. Brown FW, Lewine RJ, Hudgins PA, Risch SC. White matter hyperintensity signals in psychiatric and nonpsychiatric subjects. Am J Psychiatry 1992; 149: 620-625.
221. Swayze VW, Andreasen NC, Alliger RJ, Ehrhardt JC, Yuh WT. Structural brain abnormalities in bipolar affective disorder. Ventricular enlargement and focal signal hyperintensities. Arch Gen Psychiatry 1990; 47: 1054-1059.
222. Krabbendam L, Honig A, Weirsma J, Vuurman EFPM, Hofman PAM, Derix MMA et al. Cognitive dysfunctions and white matter lesions in patients with bipolar disorder in remission. Acta Psychiat Scand 2000; 101: 274-280.
223. Carmelli D, DeCarli C, Swan GE, Jack LM, Reed T, Wolf PA et al. Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. Stroke 1998; 29: 1177-1181.
224. Atwood LD, Wolf PA, Heard-Costa NL, Massaro JM, Beiser A, D'Agostino RB et al. Genetic variation in white matter hyperintensity volume in the Framingham Study. Stroke 2004; 35: 1609-1613.
225. Chow EW, Mikulis DJ, Zipursky RB, Scutt LE, Weksberg R, Bassett AS. Qualitative MRI findings in adults with 22q11 deletion syndrome and schizophrenia. Biol Psychiatry 1999; 46: 1436-1442.
226. Chabriat H, Vahedi K, Iba-Zizen MT, Joutel A, Nibbio A, Nagy TG et al. Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet 1995; 346: 934-939.
227. Battini R, Bianchi MC, Boespflug-Tanguy O, Tosetti M, Bonanni P, Canapicchi R et al. Unusual clinical and magnetic resonance imaging findings in a family with proteolipid protein gene mutation. Arch Neurol 2003; 60: 268-272.
228. Almkvist O, Axelman K, Basun H, Jensen M, Viitanen M, Wahlund LO et al. Clinical findings in nondemented mutation carriers predisposed to Alzheimer's disease: a model of mild cognitive impairment. Acta Neurol Scand Suppl 2003; 179: 77-82.
229. Verpillat P, Alperovitch A, Cambien F, Besancon V, Desal H, Tzourio C. Aldosterone synthase (CYP11B2) gene polymorphism and cerebral white matter hyperintensities. Neurology 2001; 56: 673-675.
230. Parkinson RB, Hopkins RO, Cleavinger HB, Weaver LK, Victoroff J, Foley JF et al. White matter hyperintensities and neuropsychological outcome following carbon monoxide poisoning. Neurology 2002; 58: 1525-1532.
231. Yamanouchi N, Okada S, Kodama K, Hirai S, Sekine H, Murakami A et al. White matter changes caused by chronic solvent abuse. AJNR Am J Neuroradiol 1995; 16: 1643-1649.
232. Lyoo IK, Streeter CC, Ahn KH, Lee HK, Pollack MH, Silveri MM et al. White matter hyperintensities in subjects with cocaine and opiate dependence and healthy comparison subjects. Psychiatry Res 2004; 131: 135-145.
233. Stojsavljevic N, Levic Z, Drulovic J, Dragutinovic G. A 44-month clinical-brain MRI follow-up in a patient with B12 deficiency. Neurology 1997; 49: 878-881.
234. Halavaara J, Brander A, Lyytinen J, Setala K, Kallela M. Wernicke's encephalopathy: is diffusion-weighted MRI useful? Neuroradiology 2003; 45: 519-523.
235. Matsusue E, Kinoshita T, Sugihara S, Fujii S, Ogawa T, Ohama E. White matter lesions in panencephalopathic type of Creutzfeldt-Jakob disease: MR imaging and pathologic correlations. AJNR Am J Neuroradiol 2004; 25: 910-918.
236. Alehan FK, Kahveci S, Uslu Y, Yildirim T, Yilmaz B. Acute disseminated encephalomyelitis associated with hepatitis A virus infection. Ann NY Acad Sci 2004; 24: 141-144.
237. Belman AL, Coyle PK, Roque C, Cantos E. MRI findings in children infected by Borrelia burgdorferi. Pediatr Neurol 1992; 8: 428-431.
238. Lane B, Sullivan EV, Lim KO, Beal DM, Harvey Jr RL, Meyers T et al. White matter MR hyperintensities in adult patients with congenital rubella. AJNR Am J Neuroradiol 1996; 17: 99-103.
239. Moore PB, El Badri SM, Cousins D, Shepherd DJ, Young AH, McAllister VL et al. White matter lesions and season of birth of patients with bipolar affective disorder. Am J Psychiatry 2001; 158: 1521-1524.
240. Ahearn EP, Speer MC, Chen YT, Steffens DC, Cassidy F, Van Meter S et al. Investigation of Notch3 as a candidate gene for bipolar disorder using brain hyperintensities as an endophenotype. Am J Med Genet (Neuropsychiat Genet) 2002; 114: 652-658.
241. Eliez S, Schmitt JE, White CD, Reiss AL. Children and adolescents with velocardiofacial syndrome: a volumetric MRI study. Am J Psychiatry 2000; 157: 409-415.
242. Levine K, Wharton R. Williams syndrome and happiness. Am J Ment Retard 2000; 105: 363-371.
243. White NS, Alkire MT, Haier RJ. A voxel-based morphometric study of nondemented adults with Down syndrome. Neuroimage 2003; 20: 393-403.
244. Kieseppa T, van Erp TG, Haukka J, Partonen T, Cannon TD, Poutanen VP et al. Reduced left hemispheric white matter volume in twins with bipolar I disorder. Biol Psychiatry 2003; 54: 896-905.
245. McDonald C, Bullmore ET, Sham PC, Chitnis X, Wickham H, Bramon E et al. Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Arch Gen Psychiatry 2004; 61: 974-984.
246. Chen HH, Nicoletti MA, Hatch JP, Sassi RB, Axelson D, Brambilla P et al. Abnormal left superior temporal gyrus volumes in children and adolescents with bipolar disorder: a magnetic resonance imaging study. Neurosci Lett 2004; 363: 65-68.
247. Brambilla P, Harenski K, Nicoletti M, Mallinger AG, Frank E, Kupfer DJ et al. Differential effects of age on brain gray matter in bipolar patients and healthy individuals. Neuropsychobiology 2001; 43: 242-247.
248. Zipursky RB, Seeman MV, Bury A, Langevin R, Wortzman G, Katz R. Deficits in gray matter volume are present in schizophrenia but not bipolar disorder. Schizophr Res 1997; 26: 85-92.
249. Lyoo IK, Kim MJ, Stoll AL, Demopulos CM, Parow AM, Dager SR et al. Frontal lobe gray matter density decreases in bipolar I disorder. Biol Psychiatry 2004; 55: 648-651.
250. Hirayasu Y, Shenton ME, Salisbury DF, Kwon JS, Wible CG, Fischer IA et al. Subgenual cingulate cortex volume in first-episode psychosis. Am J Psychiatry 1999; 156: 1091-1093.
251. Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 1998; 95: 13290-13295.
252. Castillo M, Kwock L, Courvoisie H, Hooper SR. Proton MR spectroscopy in children with bipolar affective disorder: preliminary observations. AJNR Am J Neuroradiol 2000; 21: 832-838.
253. Ellison-Wright Z, Heyman I, Frampton I, Rubia K, Chitnis X, Ellison-Wright I et al. Heterozygous PAX6 mutation, adult brain structure and fronto-striato-thalamic function in a human family. Eur J Neurosci 2004; 19: 1505-1512.
254. Yurgelun-Todd DA, Gruber SA, Kanayama G, Killgore WD, Baird AA, Young AD. fMRI during affect discrimination in bipolar affective disorder. Bipolar Disord 2000; 2: 237-248.
255. Blumberg HP, Leung HC, Skudlarski P, Lacadie CM, Fredericks CA, Harris BC et al. A functional magnetic resonance imaging study of bipolar disorder: state- and trait-related dysfunction in ventral prefrontal cortices. Arch Gen Psychiatry 2003; 60: 601-609.
256. Strakowski SM, Adler CM, Holland SK, Mills N, DelBello MP. A preliminary FMRI study of sustained attention in euthymic, unmedicated bipolar disorder. Neuropsychopharmacology 2004; 29: 1734-1740.
257. Malhi GS, Lagopoulos J, Ward PB, Kumari V, Mitchell PB, Parker GB et al. Cognitive generation of affect in bipolar depression: an fMRI study. Eur J Neurosci 2004; 19: 741-754.
258. Malhi GS, Lagopoulos J, Sachdev P, Mitchell PB, Ivanovski B, Parker GB. Cognitive generation of affect in hypomania: an fMRI study. Bipolar Disord 2004; 6: 271-285.
259. Blumberg HP, Martin A, Kaufman J, Leung HC, Skudlarski P, Lacadie C et al. Frontostriatal abnormalities in adolescents with bipolar disorder: preliminary observations from functional MRI. Am J Psychiatry 2003; 160: 1345-1347.
260. Chang K, Adleman NE, Dienes K, Simeonova DI, Menon V, Reiss A. Anomalous prefrontal-subcortical activation in familial pediatric bipolar disorder: a functional magnetic resonance imaging investigation. Arch Gen Psychiatry 2004; 61: 781-792.
261. Akiskal HS. Diagnosis and classification of affective disorders: new insights from clinical and laboratory approaches. Psychiatr Dev 1983; 1: 123-160.
262. Angst J. Psychiatric diagnoses - where next? Curr Opin Psychiatry 1997; 10: 427-428.